Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AbbVie's migraine drug cleared for migraine attacks on NHS

Summary by Pharmaphorum
AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.

3 Articles

PharmaphorumPharmaphorum
Center

AbbVie's migraine drug cleared for migraine attacks on NHS

AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, after a NICE decision.

Read Full Article
pharmatimes.compharmatimes.com

Aquipta recommended by NICE for acute migraine treatment

Guidance paves the way for NHS access for eligible adults in England and Wales

Read Full Article
The Migraine TrustThe Migraine Trust

NICE approves atogepant for acute treatment of migraine on the NHS in England

The post NICE approves atogepant for acute treatment of migraine on the NHS in England appeared first on The Migraine Trust.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Migraine Trust broke the news on Wednesday, June 10, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

NHS icon

NHS

AbbVie icon

AbbVie

United Kingdom icon

United Kingdom

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal